PMS35 QUALITY OF LIFE AMONG OUTPATIENTS WITH RHEUMATOID ARTHRITIS IN A REAL-LIFE SETTING IN GERMANY  by Deeg, M et al.
Multiple Sclerosis (MS). The primary purpose of this study was
to examine the relationship between patients’ compliance to MS
specialty medications and the total health care (pharmacy and
medical) costs. METHODS: The study was conducted using a
retrospective study design utilizing all MS-related pharmacy and
medical claims maintained by a large PBM. Patients who were
diagnosed with MS and who have had at least one prescription
for specialty medications between July-December 2005 were
identiﬁed and selected for the analysis. Patient’s compliance to
specialty medications was assessed in terms of MPR. Patients
were categorized into three different groups as—compliant
(MPR > 0.8), partially compliant (MPR 0.5–0.8), and non-
compliant (MPR < 0.5). All drug costs; all medical non drug
costs as well as total health care costs were computed and
compared across the three groups using independent t-tests.
RESULTS: A total of 104 patients met the inclusion criteria and
were included for the analysis. Compliant group patients had
signiﬁcantly high all drugs cost and signiﬁcantly lower medical
non-drug cost as compared to the non-compliant and partially
compliant groups. The total health care costs were found to be
comparable and non-signiﬁcant among the three groups. CON-
CLUSION: Patients who were compliant to their specialty medi-
cations reported higher pharmacy cost and lower medical cost,
thereby implying that there exists an inverse relationship
between compliance and medical costs.
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OBJECTIVE: To evaluate pain, physical functioning, and
health-related quality of life (HRQoL) in patients after total
knee replacement (TKR) and to identify factors affecting these
outcomes. METHODS: This was a two-year non-randomized
prospective observational cohort study in knee osteoarthritis
(OA) patients undergone who as TKR. Patients were interviewed
one week before, six months after, and two years after surgery
using a standardized questionnaire including the SF-36, the
Oxford Knee Score (OKS), and the Knee Society Clinical Rating
Scale. Repeated measures ANOVA was performed to determine
which measurements signiﬁcantly changed over time. Univariate
and multiple linear regression analyses were used to identify
factors signiﬁcantly inﬂuencing the post-surgery outcomes.
RESULTS: A total of 298 (at baseline), 176 (at 6-months), and
111 (at 2-years) eligible patients were included in the data analy-
ses. The SF-36 physical functioning and role-physical scores, the
OKS, and the Knee Society Clinical Rating Scale scores were
signiﬁcantly improved after the surgery. Being younger, of
Chinese ethnicity and having a shorter duration of OA were
associated with greater improvement in post-surgery outcomes.
CONCLUSION: Physical functioning signiﬁcantly improved
after TKR, while other health domains remained stable after the
surgery. In order to obtain optimal beneﬁts from TKR, it is
important to increase public awareness and knowledge on OA in
Asian ethnic groups.
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OBJECTIVE: To assess quality of life (QoL) of outpatients with
rheumatoid arthritis (RA) in a real-life setting in Germany.
METHODS: This is a retrospective study analyzing records of
patients suffering from RA who were treated within an ambula-
tory rheumatology specialty. We assessed demographic data,
information on medication and additional therapies. QoL was
assessed using the Short Form-36 (SF-36). We performed a base-
line analysis (t0) followed by an analysis after 3, 6, 12, 18, and
24 months (t3–t24). RESULTS: A total of 636 patients were
included in the baseline analysis: 20.3% (n = 129) were male,
mean age was 55 years and average disease duration was 5.2
years. 83.3% (n = 530) patients were diagnosed with RA at the
ﬁrst visit (t0), in 16.7% (n = 106) of the cases, the RA was
diagnosed subsequently. Longitudinal data were available for
431 patients. On all SF-36 dimensions RA patients scored sig-
niﬁcantly lower than the general population matched for gender
and age (p = 0.05): A sub-group analysis revealed the following
signiﬁcant differences: in bodily pain insurees of the statutory
health insurance scored signiﬁcantly worse than enrollees of
private health insurance plans (p < 0.01). No signiﬁcant differ-
ences were observed between female and male RA patients at
baseline. QoL was higher at each assessment compared to base-
line for all dimensions but Role Emotional and General Health.
The longitudinal analysis showed QoL improved in all but one
dimension (Role Emotional) over the observation period of 24
months. This analysis is based on the last observation carried
forward method. CONCLUSION: RA patients have a signiﬁcant
reduction of QoL compared to the general population. Results
indicate that specialist treatment may help to improve QoL.
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OBJECTIVE: Patients with rheumatoid arthritis (RA) perceive
sleep quality as an important component of their quality of life.
Sleep is multi-dimensional and the objective is to investigate what
aspects of sleep improve when patients are treated with abata-
cept. METHODS: We used data from two randomized, double-
blind clinical trials of abatacept in patients with active RA in this
study: AIM and ATTAIN, in methotrexate and anti-TNF failures
respectively. Sleep quality was assessed using the validated
Medical Outcomes Study sleep questionnaire (MOS-sleep). The
treatment groups were compared on the seven derived MOS-
sleep scales: awakened short of breath or with headache, snoring,
sleep adequacy, sleep disturbance, somnolence, and sleep prob-
lems Index I and II. In addition, sleep duration (in hours) and
optimal sleep (yes vs no) based on the MOS-sleep module were
compared. Items are scored 0–100 with higher scores indicating
more of the attribute under consideration. Since all the attributes
for the scale scores are negative, a smaller number is better except
for sleep adequacy which is a positive attribute. Optimal sleep is
a binary variable with one indicating optimal sleep, so a higher
proportion on this variable is better. RESULTS: There was no
pertinent difference at baseline in the various items on the MOS
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